Sei Investments Co. Sells 139,855 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sei Investments Co. trimmed its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 21.7% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 504,934 shares of the medical instruments supplier’s stock after selling 139,855 shares during the period. Sei Investments Co. owned about 0.25% of DENTSPLY SIRONA worth $9,584,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in XRAY. UMB Bank n.a. grew its holdings in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 564 shares in the last quarter. MML Investors Services LLC grew its stake in DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after purchasing an additional 620 shares during the period. Blue Trust Inc. increased its position in shares of DENTSPLY SIRONA by 10.9% during the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock valued at $137,000 after purchasing an additional 707 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,232 shares during the period. Finally, Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter worth about $26,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 0.52% of the stock is currently owned by insiders.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $14.93 on Monday. DENTSPLY SIRONA Inc. has a 52-week low of $14.78 and a 52-week high of $33.22. The stock has a fifty day moving average of $17.62 and a 200 day moving average of $20.16. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market capitalization of $2.97 billion, a price-to-earnings ratio of -7.21, a P/E/G ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.29%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.07%.

Analyst Upgrades and Downgrades

XRAY has been the topic of several research reports. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. UBS Group decreased their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Barrington Research dropped their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. Finally, Evercore ISI reissued an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.